EyePoint Pharmaceuticals (NASDAQ:EYPT – Get Free Report) will issue its quarterly earnings data before the market opens on Wednesday, November 1st. Analysts expect the company to announce earnings of ($0.62) per share for the quarter. EyePoint Pharmaceuticals (NASDAQ:EYPT – Get Free Report) last issued its quarterly earnings results on Wednesday, August 2nd. The company reported […]
Cantor Fitzgerald reiterated their overweight rating on shares of EyePoint Pharmaceuticals (NASDAQ:EYPT – Free Report) in a research report report published on Thursday morning, Benzinga reports. Cantor Fitzgerald currently has a $31.00 target price on the stock. A number of other research analysts have also weighed in on EYPT. StockNews.com initiated coverage on shares of […]
EyePoint Pharmaceuticals (NASDAQ:EYPT – Get Free Report)‘s stock had its “overweight” rating reiterated by analysts at Cantor Fitzgerald in a research report issued to clients and investors on Thursday, Benzinga reports. They presently have a $31.00 target price on the stock. Cantor Fitzgerald’s target price suggests a potential upside of 207.23% from the company’s current […]
EyePoint Pharmaceuticals (NASDAQ:EYPT) Trading Down 5.1% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
EyePoint Pharmaceuticals (NASDAQ: EYPT) has recently received a number of price target changes and ratings updates: 8/11/2023 – EyePoint Pharmaceuticals was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating. 8/3/2023 – EyePoint Pharmaceuticals was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating. 8/3/2023 – EyePoint […]